These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4405360)

  • 21. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 22. [Differentiation with practolol of the type of beta adrenergic receptor involved in insulin secretion].
    Mariani MM; Loubatières A; Chapal J; Savi L; Sorel G
    C R Seances Soc Biol Fil; 1970; 164(7):1596-600. PubMed ID: 4396555
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of adrenergic receptor blockaders on the hypoglycemic action of glibenclamide].
    Hopps V; Mantia G; Leone F
    Boll Soc Ital Biol Sper; 1971 Nov; 47(21):733-6. PubMed ID: 4401856
    [No Abstract]   [Full Text] [Related]  

  • 24. Beta-blocking drugs and human platelet aggregation in vitro.
    Gibelli A; Montanari C; Bellani D; Mandelli V; Sacchetti G
    Experientia; 1973 Feb; 29(2):186-7. PubMed ID: 4144249
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of insulin secretion by aryl-substituted secondary aminoethanols.
    Bressler R; Vargas-Cordon M; Brendel K
    Diabetes; 1969 May; 18(5):262-7. PubMed ID: 4307639
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
    Range H; Bischoff M; Siess M
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
    [No Abstract]   [Full Text] [Related]  

  • 27. [Studies on the effect of various sulfonylureas during adrenergic blockade of the insulin secretion in man].
    Haslbeck M; Brauch K; Hepp KD; Mehnert H
    Verh Dtsch Ges Inn Med; 1971; 77():543-6. PubMed ID: 5005529
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of trimepranol on somatotropin, insulin, glucose and nonesterified fatty acid levels in man].
    Nedvídková J; Felt V
    Cas Lek Cesk; 1973 Aug; 112(34):1041-5. PubMed ID: 4147310
    [No Abstract]   [Full Text] [Related]  

  • 29. Abolition of dopaminergic insulin secretion by beta-adrenergic antagonism.
    Cyrus J; Stagner J; Samols E
    Endocrinology; 1982 Jul; 111(1):214-8. PubMed ID: 6123430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of oxprenolol (Trasicor, Ciba 39089-Ba) on patterns of urinary sodium excretion in man.
    Singh BN; Till MR; Kelly DT
    Am J Cardiol; 1971 Apr; 27(4):372-5. PubMed ID: 4396725
    [No Abstract]   [Full Text] [Related]  

  • 31. A mechanism for regulation of insulin release in hypoxia.
    Baum D; Porte D
    Am J Physiol; 1972 Mar; 222(3):695-9. PubMed ID: 4401851
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of trimepranol on somatotropin, insulin, glucose and on serum free fatty acids in thyrotoxicosis].
    Felt V; Nedvídková J
    Vnitr Lek; 1973 Apr; 19(4):374-8. PubMed ID: 4144647
    [No Abstract]   [Full Text] [Related]  

  • 34. Phentolamine blocks the somatostatin-mediated inhibition of insulin secretion.
    Smith PH; Woods SC; Porte D
    Endocrinology; 1976 Apr; 98(4):1073-6. PubMed ID: 776596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of chronic adrenergic blockade on the inhibition by epinephrine of growth hormone and insulin release in sheep.
    Hertelendy F; Takahashi K; Machlin LJ; Kipnis DM
    Horm Metab Res; 1970 Sep; 2(5):257-9. PubMed ID: 4400839
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of alpha- and beta adrenergic receptor blockaders on the secretory response of pancreatic beta cells in thyrotoxicosis].
    Zhurova TE; Lugovaia NA; Poltorak VV; Iurchenko MZ
    Ter Arkh; 1982; 54(10):36-9. PubMed ID: 6129711
    [No Abstract]   [Full Text] [Related]  

  • 37. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 38. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):227-33. PubMed ID: 190857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124].
    Fujita T; Miyazaki M
    Masui; 1972 May; 21(5):450-7. PubMed ID: 4403862
    [No Abstract]   [Full Text] [Related]  

  • 40. Profile of insulin release due to intrapancreatic glyburide infusion.
    Colwell AR; Zuckerman L
    Diabetes; 1972 Apr; 21(4):209-15. PubMed ID: 4622788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.